These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9710881)

  • 21. Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis.
    Dougados M
    Z Rheumatol; 1998 Feb; 57(1):31-3. PubMed ID: 9566104
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rheumatoid arthritis: lower work loss during treatment with biologicals?--Modern treatment principles reduce work loss in rheumatoid arthritis].
    Krüger K
    Dtsch Med Wochenschr; 2013 Oct; 138(44):2236. PubMed ID: 24150698
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
    Wollenhaupt J; Zeidler H
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1219-23. PubMed ID: 9378046
    [No Abstract]   [Full Text] [Related]  

  • 24. Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.
    van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; van Zeben D; Kerstens PJ; Gerards AH; van Groenendael JH; Hazes JM; Breedveld FC; Allaart CF; Dijkmans BA
    Ann Rheum Dis; 2007 Oct; 66(10):1356-62. PubMed ID: 17293364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
    Zheng N; Guo C; Wu R
    Scand J Rheumatol; 2018 Sep; 47(5):422-424. PubMed ID: 29318937
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effective combination therapy of TNF antagonists with DMARDs].
    Ohtsubo H; Matsuda T
    Nihon Rinsho; 2007 Jul; 65(7):1287-91. PubMed ID: 17642245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conventional DMARD options for patients with a suboptimal response to methotrexate.
    O'Dell J
    J Rheumatol Suppl; 2001 Jun; 62():21-6. PubMed ID: 11409154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients.
    Elkayam O; Yaron M; Zhukovsky G; Segal R; Caspi D
    Rheumatol Int; 1997; 17(2):49-53. PubMed ID: 9266620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
    Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
    Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.
    de Jong PH; Hazes JM; Barendregt PJ; Huisman M; van Zeben D; van der Lubbe PA; Gerards AH; de Jager MH; de Sonnaville PB; Grillet BA; Luime JJ; Weel AE
    Ann Rheum Dis; 2013 Jan; 72(1):72-8. PubMed ID: 22679301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Not better but quite good: effects on work loss of combination treatment for rheumatoid arthritis with and without biological agents.
    Yelin E
    JAMA Intern Med; 2013 Aug; 173(15):1414-5. PubMed ID: 23817526
    [No Abstract]   [Full Text] [Related]  

  • 34. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
    Eriksson JK; Neovius M; Bratt J; Petersson IF; van Vollenhoven RF; Geborek P; Ernestam S
    JAMA Intern Med; 2013 Aug; 173(15):1407-14. PubMed ID: 23817631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.
    Rains CP; Noble S; Faulds D
    Drugs; 1995 Jul; 50(1):137-56. PubMed ID: 7588084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
    O'Dell JR
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S; Rau R
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis.
    Marguerie L; Flipo RM; Grardel B; Beaurain D; Duquesnoy B; Delcambre B
    Joint Bone Spine; 2002 May; 69(3):275-81. PubMed ID: 12102274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatoid arthritis: not yet curable with early intensive therapy.
    Emery P
    Lancet; 1997 Aug; 350(9074):304-5. PubMed ID: 9251629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.